// App-Quantinova.ai

OA01 : No difference in risk of myocardial infarction among patients receiving either IL6 or TNF inhibitors for rheumatoid arthritis

Researchers

Presenter

  • Zixing Tian

Principal Investigators

  • Lianne Kearsley-Fleet

  • Kim Lauper

  • Sally Haughton

  • Kath Watson

  • Mark Lunt

  • John McLaughlin

  • Arpana Verma

  • Kimme L Hyrich

Medical Centers

  • National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

  • Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom

  • Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom

  • Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, the University of Manchester, Manchester, United Kingdom

  • Division of Rheumatology, Department of Internal Medicine and Department of Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland

  • Division of Diabetes, Endocrinology & Gastroenterology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Myocardial infarction

  • Rheumatoid arthritis

  • Inflammatory Arthritis

Biomarkers

  • Interleukin 6

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved